Experimental drug combo tested for tough lung cancer – study halted early
Disease control
Terminated
This study tested two experimental drugs, AK119 and AK112, with or without chemotherapy, in 59 adults with advanced non-squamous lung cancer that has a specific EGFR gene change and stopped responding to standard targeted therapy. The goal was to see if the combination is safe an…
Phase: PHASE1, PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC